Press Releases

 
Press Releases
  Date Title and Summary View
Mar 4, 2015
REDWOOD CITY, Calif., March 4, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on March 2, 2015, the compensation committee of the company's board of directors granted two new employees options to purchase an aggregate of 9,200 shares of the company's common stock with a per share exercise pri...
Mar 3, 2015
REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the closing of its public offering of 4,485,000 shares of its common stock at a price to the public of $38.50 per share for gross proceeds of approximately $172.3 million, which includes the exercise in full by the under...
Mar 2, 2015
REDWOOD CITY, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that Kristine M. Ball, senior vice president and chief financial officer, will present at the 27th Annual ROTH Conference on March 10, 2015 at 9:30 a.m. PT. To access the live webcasts and subsequent archived recordings of these presentation...
Feb 25, 2015
REDWOOD CITY, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,900,000 shares of its common stock at a price to the public of $38.50 per share, before underwriting discounts, for gross proceeds of approximately $150 million. In ad...
Feb 24, 2015
REDWOOD CITY, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that it has commenced an underwritten public offering of up to $130,000,000 of shares of its common stock. All of the shares of the common stock to be sold in the offering will be offered by Relypsa. In addition, Relypsa...
Feb 24, 2015
REDWOOD CITY, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on February 17, 2015, the compensation committee of the company's board of directors granted four new employees options to purchase an aggregate of 57,000 shares of the company's common stock with a per share exerci...
Feb 23, 2015
REDWOOD CITY, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the Cowen and Company 35th Annual Healthcare Conference on March 3, 2015 at 8:40 a.m. ET. To access the live webcasts and subsequent archived recordings of these pres...
Feb 4, 2015
REDWOOD CITY, Calif., Feb. 4, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on February 2, 2015, the compensation committee of the company's board of directors granted nine new employees an option to purchase an aggregate of 41,400 shares of the company's common stock with a per share exerci...
Feb 2, 2015
REDWOOD CITY, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the 17th Annual BIO CEO & Investor Conference on February 10, 2015 at 9:00 a.m. ET. To access the live webcasts and subsequent archived recordings of these presentatio...
Jan 22, 2015
REDWOOD CITY, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that Helen Torley, M.B. Ch.B., M.R.C.P., has been appointed to the company's board of directors, bringing the number of directors to nine. Dr. Torley, current president and chief executive officer of Halozyme Therapeutics, brings to the board signif...
Page:
1
... NextLast
= add release to Briefcase